1. Home
  2. PW vs ARTL Comparison

PW vs ARTL Comparison

Compare PW & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PW

Power REIT (MD)

HOLD

Current Price

$1.04

Market Cap

2.9M

Sector

Real Estate

ML Signal

HOLD

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.74

Market Cap

3.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PW
ARTL
Founded
1967
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
3.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PW
ARTL
Price
$1.04
$1.74
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$30.00
AVG Volume (30 Days)
2.0M
1.2M
Earning Date
10-24-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,075,489.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$1.52
52 Week High
$1.96
$28.60

Technical Indicators

Market Signals
Indicator
PW
ARTL
Relative Strength Index (RSI) 59.08 34.98
Support Level $0.91 $1.75
Resistance Level $1.10 $1.93
Average True Range (ATR) 0.12 0.22
MACD 0.01 0.06
Stochastic Oscillator 78.66 17.82

Price Performance

Historical Comparison
PW
ARTL

About PW Power REIT (MD)

Power REIT is an internally managed real estate investment trust (REIT) that owns a portfolio of real estate assets related to transportation, energy infrastructure, and Controlled Environment Agriculture (CEA) in the United States. Its investment portfolio comprises solar farm lands, railroad real estate, and various Controlled Environment Agriculture properties in the form of greenhouses for the cultivation of food and cannabis. In addition, the company is focused on opportunities in the form of investing in distressed situations, including debt and other types of secured interests in real estate, distressed properties, and real estate-related companies.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: